OPKO Health, Inc.

OPK Healthcare Diagnostics & Research

OPKO Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.9 million, down 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS grew 94.7%, free cash flow grew 46.5% and total debt rose 6.37%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.53 0.08 −4.97%
Market cap
$1.2B
P/E
0.0×
Fwd P/E
−4.7×
Dividend yield
—
F-score
4/9
Altman Z
−0.42
Beneish M
−2.81
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.88 1.56 1.49 1.93
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(34.77) (36.51) (44.80) (26.04)
P/B ratio
0.92 0.75 0.72 0.96
Price to Tangible BV
4.21 3.54 3.83 5.03
EV/Sales
1.90 1.51 1.49 2.01
EV/EBITDA
0.00 0.00 0.00 28.07
EV/Operating CF
(6.19) (5.15) (5.31) (9.56)
EV/FCF
(5.50) (4.58) (4.71) (8.21)
Quick Ratio
3.01 3.13 2.84 2.56
Current Ratio
3.70 3.97 3.61 3.35
Net Debt/EBITDA
(1.22) 1.73 (0.06) 2.99
Debt/Assets
16.48% 17.69% 18.51% 18.98%
Debt/Equity
0.25 0.27 0.29 0.29
Asset Turnover
0.30 0.29 0.29 0.31
Operating CF/Net income
(1.60) 0.83 0.35 5.17
Capex/Depreciation
(0.14) (0.11) (0.08) (0.13)
Interest Coverage
4.23 (3.39) (4.66) (0.61)
Research and Development Expense of Revenue
19.83% 22.08% 23.51% 20.28%
Selling, General and Administrative Expense of Revenue
35.47% 34.03% 39.14% 32.35%
Intangible Assets out of Total Assets
0.51 0.52 0.53 0.52
Share Based Compensation of Revenue
1.96% 1.96% 2.20% 1.37%
Graham Net Nets
(0.05) (0.09) (0.13) (0.13)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(15.48%) (23.81%) (23.68%) (6.00%)
Free Cash Flow Yield
(18.41%) (21.19%) (21.26%) (12.69%)
Revenue per Share
0.20 0.20 0.16 0.22
Operating CF per Share
(0.04) (0.03) (0.03) (0.06)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.05) (0.04) (0.03) (0.06)
Cash per Share
0.53 0.49 0.45 0.40
Shareholders Equity per Share
1.68 1.69 1.59 1.57
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
1.68 1.69 1.59 1.57
Free Cash Flow
(37.77) (28.49) (21.11) (46.36)
Working Capital
457.81 435.20 386.98 350.87
Capital Expenditures
(3.12) (2.57) (1.80) (2.86)
Net Current Asset Value
(62.89) (82.10) (116.82) (145.05)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.02 0.02 0.01 0.02
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
100.58 104.14 87.89 90.63
Average Payables
56.77 44.09 51.77 53.36
Average Inventory
62.18 61.31 64.20 64.10
Average Assets
2,125.81 2,066.08 1,992.56 1,901.22
Average Common Equity
1,354.45 1,316.70 1,258.14 1,240.54

Fold the line items

Columns are period end dates